Valuation : TransMedics Group, Inc.

Market Cap 3B 2.58B 2.43B 2.21B 4.14B 286B 4.18B 28.95B 11.14B 145B 11.25B 11B 461B P/E 2026 *
62x
P/E 2027 * 39.3x
Enterprise Value 2.96B 2.54B 2.4B 2.18B 4.08B 283B 4.12B 28.56B 10.99B 143B 11.1B 10.86B 455B EV / Sales 2026 *
3.98x
EV / Sales 2027 * 3.26x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.22%
1 week-1.93%
Current month+0.51%
1 month-3.52%
3 months+14.08%
6 months-34.81%
Current year-29.88%
1 week 83.61
Extreme 83.61
90.11
1 month 81.34
Extreme 81.3401
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap. Importance
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
10/07/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-1.93%-20.86%+43.29% 3B
-0.27%-2.32%+26.76%+17.31% 224B
-1.44%-4.25%+4.91%-19.23% 144B
+2.20%-2.43%-19.81%+19.35% 125B
-3.36%-7.10%-58.55%-20.06% 65.16B
-0.70%-1.00%-20.42%-15.11% 50.05B
+0.45%-3.61%+10.55%+15.58% 49.67B
-1.31%-4.59%+15.29%+26.53% 40.81B
-0.96%-2.97%+36.93%+52.40% 39.77B
-0.91%-8.53%+112.34%+31.02% 30.96B
Average -0.78%-1.96%+8.71%+15.11% 77.22B
Weighted average by Cap. -0.48%-2.27%+7.02%+8.40%

Financials

2026 *2027 *
Net sales 742M 638M 602M 548M 1.02B 70.91B 1.03B 7.17B 2.76B 35.97B 2.79B 2.72B 114B 875M 752M 710M 647M 1.21B 83.63B 1.22B 8.45B 3.25B 42.42B 3.28B 3.21B 135B
Net income 51.99M 44.71M 42.18M 38.43M 71.84M 4.97B 72.49M 502M 193M 2.52B 195M 191M 8.01B 89.08M 76.61M 72.28M 65.85M 123M 8.52B 124M 861M 331M 4.32B 335M 327M 13.72B
Net Debt -40.26M -34.62M -32.67M -29.76M -55.63M -3.85B -56.14M -389M -150M -1.95B -151M -148M -6.2B -146M -125M -118M -108M -201M -13.93B -203M -1.41B -542M -7.06B -547M -535M -22.43B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
10/09/26 $85.22 -1.37% 220,589
09/09/26 $86.40 -2.12% 665,155
08/09/26 $88.27 -1.90% 594,550
04/09/26 $89.98 +3.45% 542,804
03/09/26 $86.98 +3.19% 574,877
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
86.40USD
Average target price
97.30USD
Spread / Average Target
+12.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!